• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在培养细胞中测量癌症药物敏感性和耐药性

Measuring Cancer Drug Sensitivity and Resistance in Cultured Cells.

作者信息

Niepel Mario, Hafner Marc, Chung Mirra, Sorger Peter K

机构信息

HMS LINCS Center, Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.

出版信息

Curr Protoc Chem Biol. 2017 Jun 19;9(2):55-74. doi: 10.1002/cpch.21.

DOI:10.1002/cpch.21
PMID:28628199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5538315/
Abstract

Measuring the potencies of small-molecule drugs in cell lines is a critical aspect of preclinical pharmacology. Such experiments are also prototypical of high-throughput experiments in multi-well plates. The procedure is simple in principle, but many unrecognized factors can affect the results, potentially making data unreliable. The procedures for measuring drug response described here were developed by the NIH LINCS program to improve reproducibility. Key features include maximizing uniform cell growth during the assay period, accounting for the effects of cell density on response, and correcting sensitivity measures for differences in proliferation rates. Two related protocols are described: one involves an endpoint measure well-suited to large-scale studies and the second is a time-dependent measurement that reveals changes in response over time. The methods can be adapted to other types of plate-based experiments. © 2017 by John Wiley & Sons, Inc.

摘要

在细胞系中测定小分子药物的效力是临床前药理学的一个关键方面。此类实验也是多孔板高通量实验的典型代表。该程序原则上很简单,但许多未被认识到的因素会影响结果,可能导致数据不可靠。此处描述的测量药物反应的程序由美国国立卫生研究院(NIH)的LINCS计划开发,以提高可重复性。关键特征包括在测定期间使细胞生长最大化均匀,考虑细胞密度对反应的影响,以及针对增殖率差异校正敏感性测量。描述了两个相关方案:一个涉及适用于大规模研究的终点测量,另一个是随时间变化的测量,可揭示反应随时间的变化。这些方法可适用于其他类型的基于平板的实验。©2017约翰威立国际出版公司

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/47c873d241bf/nihms879267f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/47c7c353e942/nihms879267f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/affb5d7e3158/nihms879267f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/42f5efc292e6/nihms879267f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/592fbe45338f/nihms879267f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/47c873d241bf/nihms879267f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/47c7c353e942/nihms879267f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/affb5d7e3158/nihms879267f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/42f5efc292e6/nihms879267f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/592fbe45338f/nihms879267f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172f/5538315/47c873d241bf/nihms879267f5.jpg

相似文献

1
Measuring Cancer Drug Sensitivity and Resistance in Cultured Cells.在培养细胞中测量癌症药物敏感性和耐药性
Curr Protoc Chem Biol. 2017 Jun 19;9(2):55-74. doi: 10.1002/cpch.21.
2
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.生长速率抑制指标可校正癌症药物敏感性测量中的混杂因素。
Nat Methods. 2016 Jun;13(6):521-7. doi: 10.1038/nmeth.3853. Epub 2016 May 2.
3
Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.长期血清饥饿条件下生长的肺癌和乳腺癌细胞的化疗耐药性
J Cell Physiol. 2017 Aug;232(8):2033-2043. doi: 10.1002/jcp.25514. Epub 2017 Feb 28.
4
Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics.使用 GR 指标定量检测乳腺癌细胞系对抗癌药物的敏感性和耐药性。
Sci Data. 2017 Nov 7;4:170166. doi: 10.1038/sdata.2017.166.
5
The AutoDiSC: development and validation of a novel chemotherapy sensitivity and resistance assay.AutoDiSC:一种新型化疗敏感性和耐药性检测方法的开发和验证。
Anticancer Res. 2013 Jun;33(6):2491-8.
6
Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.药物设计与测试:使用基于细胞的甲基 - [³H] - 胸苷掺入试验对用于癌症治疗的抗增殖药物进行分析。
Methods Mol Biol. 2011;731:451-65. doi: 10.1007/978-1-61779-080-5_36.
7
Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.乳腺癌MCF-7细胞二维单层和三维球体对柔红霉素、多西他赛和二硫化二砷的化疗敏感性
Anticancer Res. 2018 Apr;38(4):2101-2108. doi: 10.21873/anticanres.12450.
8
Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.利用基于微孔的琼脂糖支架生成用于药物测试的多细胞肿瘤球体。
PLoS One. 2015 Jun 19;10(6):e0130348. doi: 10.1371/journal.pone.0130348. eCollection 2015.
9
Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.载抗癌药物的固体脂质纳米粒逆转多药耐药癌细胞耐药性的研究。
Colloids Surf B Biointerfaces. 2013 Oct 1;110:74-80. doi: 10.1016/j.colsurfb.2013.03.037. Epub 2013 Apr 17.
10
Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.由硫代氨基脲和蒽衍生的席夫碱在体外克服多药耐药性方面显示出高潜力,且耐药指数低。
Drug Des Devel Ther. 2017 Jul 31;11:2227-2237. doi: 10.2147/DDDT.S138371. eCollection 2017.

引用本文的文献

1
Optimizing Cell Density and Unveiling Cytotoxic Profiles of DMSO and Ethanol in Six Cancer Cell Lines: Experimental and In Silico Insights.优化六种癌细胞系中的细胞密度并揭示二甲基亚砜(DMSO)和乙醇的细胞毒性特征:实验与计算机模拟见解
Methods Protoc. 2025 Aug 10;8(4):93. doi: 10.3390/mps8040093.
2
Sorption and release of small molecules in PDMS and COC for Organs on chip.用于芯片器官的聚二甲基硅氧烷(PDMS)和环烯烃共聚物(COC)中小分子的吸附与释放
Sci Rep. 2025 Apr 23;15(1):14012. doi: 10.1038/s41598-025-97111-2.
3
Regulatory role of CD177+ neutrophils in BMP signaling pathway and its implications for inflammatory bowel disease, sepsis, and intestinal tumors.

本文引用的文献

1
Assessment of pharmacogenomic agreement.药物基因组学一致性评估。
F1000Res. 2016 May 9;5:825. doi: 10.12688/f1000research.8705.1. eCollection 2016.
2
A combinatorial strategy for treating KRAS-mutant lung cancer.一种治疗KRAS突变型肺癌的联合策略。
Nature. 2016 Jun 30;534(7609):647-51. doi: 10.1038/nature18600. Epub 2016 Jun 22.
3
Reproducible pharmacogenomic profiling of cancer cell line panels.可重现的癌症细胞系panel 的药物基因组学分析。
CD177⁺中性粒细胞在骨形态发生蛋白信号通路中的调节作用及其对炎症性肠病、脓毒症和肠道肿瘤的影响
Transl Oncol. 2025 May;55:102336. doi: 10.1016/j.tranon.2025.102336. Epub 2025 Mar 29.
4
Application of drug-induced growth rate inhibition and intracellular drug exposures for comprehensive evaluation of cellular drug sensitivity.药物诱导的生长速率抑制和细胞内药物暴露在细胞药物敏感性综合评估中的应用。
Sci Rep. 2025 Feb 11;15(1):5064. doi: 10.1038/s41598-025-86919-7.
5
Electrode Droplet Microarray (eDMA): An Impedance Platform for Label-Free Parallel Monitoring of Cellular Drug Response in Nanoliter Droplets.电极液滴微阵列(eDMA):一种用于在纳升液滴中对细胞药物反应进行无标记并行监测的阻抗平台。
Adv Healthc Mater. 2025 Jan;14(3):e2402046. doi: 10.1002/adhm.202402046. Epub 2024 Oct 15.
6
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.单细胞类器官分析揭示了胰腺癌中具有临床相关性的耐药和侵袭性子克隆。
NPJ Precis Oncol. 2023 Dec 8;7(1):128. doi: 10.1038/s41698-023-00480-y.
7
Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens.自动化、活细胞成像和终点细胞活力检测在前列腺癌药物筛选中的应用。
PLoS One. 2023 Oct 10;18(10):e0287126. doi: 10.1371/journal.pone.0287126. eCollection 2023.
8
Optimization of Cell Viability Assays for Drug Sensitivity Screens.优化细胞活力检测法以用于药物敏感性筛选。
Methods Mol Biol. 2023;2644:287-302. doi: 10.1007/978-1-0716-3052-5_18.
9
Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors.多低剂量疗法:使用 ATR 和 CHK1 抑制剂有效杀伤高级别浆液性卵巢癌细胞。
NAR Cancer. 2022 Nov 12;4(4):zcac036. doi: 10.1093/narcan/zcac036. eCollection 2022 Dec.
10
Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop.使用 Dye Drop 对活细胞和固定细胞进行多重且可重现的高内涵筛选。
Nat Commun. 2022 Nov 14;13(1):6918. doi: 10.1038/s41467-022-34536-7.
Nature. 2016 May 19;533(7603):333-7. doi: 10.1038/nature17987.
4
An unbiased metric of antiproliferative drug effect in vitro.体外抗增殖药物作用的无偏倚指标。
Nat Methods. 2016 Jun;13(6):497-500. doi: 10.1038/nmeth.3852. Epub 2016 May 2.
5
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.生长速率抑制指标可校正癌症药物敏感性测量中的混杂因素。
Nat Methods. 2016 Jun;13(6):521-7. doi: 10.1038/nmeth.3853. Epub 2016 May 2.
6
Pharmacogenomic agreement between two cancer cell line data sets.两个癌细胞系数据集之间的药物基因组学协议。
Nature. 2015 Dec 3;528(7580):84-7. doi: 10.1038/nature15736. Epub 2015 Nov 16.
7
Patient-derived models of acquired resistance can identify effective drug combinations for cancer.患者来源的获得性耐药模型可识别出针对癌症的有效联合用药方案。
Science. 2014 Dec 19;346(6216):1480-6. doi: 10.1126/science.1254721. Epub 2014 Nov 13.
8
Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes.拒绝 DMSO:二甲基亚砜使顺铂、卡铂和其他铂络合物失活。
Cancer Res. 2014 Jul 15;74(14):3913-22. doi: 10.1158/0008-5472.CAN-14-0247. Epub 2014 May 8.
9
A one-step imaging assay to monitor cell cycle state and apoptosis in mammalian cells.一种用于监测哺乳动物细胞周期状态和凋亡的一步成像检测法。
Curr Protoc Chem Biol. 2014 Mar 14;6(1):1-5. doi: 10.1002/9780470559277.ch130140.
10
Inconsistency in large pharmacogenomic studies.大型药物基因组学研究中的不一致性。
Nature. 2013 Dec 19;504(7480):389-93. doi: 10.1038/nature12831. Epub 2013 Nov 27.